Healthcare - Press Releases

SHANGHAI, March 23, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has received 2025 CDMO Leadership Awards in the "Biologics - Global" category. It has also been recognized for excellence in "Best Scientific Expertise", "Best Seamless Delivery Across Phases", "Best Innovative Approach to Technology and Process Execution", making it the most lauded company in the ceremony.

Achieves International Recognition with HIMSS Award for Excellence in Smart Healthcare

HONG KONG, March 23, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced on March 21st, 2025 its financial results for fiscal year 2024, reporting total revenue of RMB 2.7 billion, representing an 11.2% year-over-year increase. Notably, the company's adjusted net profit reached RMB 17.2 million, a significant 139% growth compared to 2023, driven by ongoing technology enhancements and improvements in operating efficiency.

BOSTON, March 23, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has agreed to sell an aggregate of 10,250,000 shares of its common stock and warrants to purchase up to 10,250,000 shares of common stock priced at-the-market under Nasdaq rules, at a purchase price of $0.98 per share and associated warrant. The warrants will have an exercise price of $0.86 per share and will be immediately exercisable upon issuance for a period of five years following the date of issuance. All of the shares of common stock and associated warrants are being offered by the Company. The offering is expected to close on March 25, 2025, subject to satisfaction of customary closing conditions.

SEATTLE, March 24, 2025 /PRNewswire/ -- The surge in online supplement sales has led to a troubling rise in counterfeit products infiltrating e-commerce platforms, deceiving buyers with misleading packaging and false advertising. PurDentix, Bioventra's brand, a well-established name in health and wellness, is issuing a consumer warning regarding unauthorized resellers distributing imitation versions of its product. The company has identified multiple fraudulent listings across online marketplaces, raising concerns about product authenticity and customer safety.

TOKYO, March 24, 2025 /PRNewswire/ -- The long-term care robot portal site management office released the English version of the "Long-term Care Tech Portal" (https://robotcare.jp/en/home/index?type=pw), a portal site providing information on state-of-the-art care and age tech in Japan.

TOKYO, March 24, 2025 /PRNewswire/ -- The long-term care robot portal site management office released the English version of the "Long-term Care Tech Portal" (https://robotcare.jp/en/home/index?type=pw), a portal site providing information on state-of-the-art care and age tech in Japan.

STOCKHOLM, March 24, 2025 /PRNewswire/ -- The hygiene and health companyEssity will publish its interim report for quarter 1, 2025 on April 24 at approximately 07:00 CET. President and CEO Magnus Groth and Executive Vice President and CFO Fredrik Rystedt will present the interim report at a live webcast and teleconference at 09:00 CET the same day.

STOCKHOLM, March 24, 2025 /PRNewswire/ -- The hygiene and health companyEssity will publish its interim report for quarter 1, 2025 on April 24 at approximately 07:00CET. President and CEO Magnus Groth and Executive Vice President and CFO Fredrik Rystedt will present the interim report at a live webcast and teleconference at 09:00 CET the same day.

MILAN, March 24, 2025 /PRNewswire/ -- Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has received CE Mark approval for its AlphaDBS device, a next-generation closed-loop DBS system that dynamically adjusts stimulation based on real-time brain signals. This approval enables the company to commercialize AlphaDBS in Europe, bringing an innovative treatment option to patients living with Parkinson's disease and other neurological disorders.

MILAN, 24 mars 2025 /PRNewswire/ -- Newronika, leader de la neuromodulation et de la technologie de stimulation crbrale profonde (SCP) adaptative, a annonc aujourd'hui avoir reu l'approbation du marquage CE pour son dispositif AlphaDBS, un systme de SCP de nouvelle gnration fonctionnant en boucle ferme, et qui ajuste dynamiquement la stimulation en fonction des signaux crbraux en temps rel. Cette approbation permet l'entreprise de commercialiser AlphaDBS en Europe, offrant ainsi une option thrapeutique innovante aux patients atteints de la maladie de Parkinson et d'autres troubles neurologiques.

MAILAND, 24. Mrz 2025 /PRNewswire/ -- Newronika, ein fhrendes Unternehmen im Bereich der Neuromodulation und adaptiven Tiefenhirnstimulation (THS), gab heute bekannt, dass es die CE-Kennzeichnung fr sein AlphaDBS-Gert erhalten hat, ein THS-System der nchsten Generation mit geschlossenem Regelkreis, das die Stimulation dynamisch auf der Grundlage von Echtzeit-Gehirnsignalen anpasst. Diese Zulassung ermglicht es dem Unternehmen, AlphaDBS in Europa zu vermarkten und Patienten mit Parkinson und anderen neurologischen Erkrankungen eine innovative Behandlungsmglichkeit zu bieten.

Rise in prevalence of cardiovascular diseases (CVDS), expanding applications in pain management & fever reduction, and government & healthcare initiatives promoting preventive medicine drive the growth of the global aspirin drugs market.

NORTH CHICAGO, Ill., March 24, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, the industry leader in aesthetics globally, demonstrates how to elevate the patient experience and achieve optimal treatment outcomes with new AA Signature program at the Anti-Aging and Aesthetics Medicine World Congress (AMWC) in Monaco from Thursday, March 27- Saturday, March 29, 2025.

SHANGHAI and HONG KONG, March 21, 2025 /PRNewswire/ --Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2024, along with several significant milestones achieved in recent months.

The Company reaffirms previously provided preliminary financial results for the quarter and full year ended December 31, 2024, and continues to expect regulatory decisions on DrugSorb-ATR marketing applications in 2025

BEIJING, March 21, 2025 /PRNewswire/ --Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leaderAstraZenecato develop potential first-in-class macrocyclic peptides for the treatment of chronic diseases.Under this collaboration,AstraZeneca will gain access toSyneron Bio's innovative Synova platform, an intelligentand high-throughput macrocyclic peptide drug research and development platform, designed to support the advancements of research programmes exploring possible future treatments of chronic diseases,including rare, autoimmune,and metabolic disease.

Announced merger agreement with Cullgen in November, anticipated to close in the first half of 2025

- Convocatoria final: EIT Jumpstarter 2025 da la bienvenida a innovadores de toda Europa, con especial atencin a los Balcanes, el Mediterrneo y las regiones ultraperifricas de la UE

HAYWARD, Calif., March 21, 2025 /PRNewswire/ -- Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal monitoring and assessment based on global clinical practice guidelines, today announced that Todd Dunn, Accuryn's Chief Transformation Officer, will transition to a new role leading the company as Chief Executive Officer. Dunn succeeds Sanjay Banerjee, who is stepping down from his role as CEO.

MUMBAI, India and Oldenzaal, Netherlands, March 21, 2025 /PRNewswire/ -- Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug Delivery, during the Drug, Chemical and Associated Technologies Association (DCAT) week at New York.

MUMBAI, India and Oldenzaal, Netherlands, March 21, 2025 /PRNewswire/ -- Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug Delivery, during the Drug, Chemical and Associated Technologies Association (DCAT) week at New York.

GILBERT, Ariz., 21 de marzo de 2025 /PRNewswire-HISPANIC PR WIRE/ -- Recibir atencin mdica de calidad ahora es ms fcil en Gilbert! MY DR NOW est abriendo una nueva clnica de atencin primaria diseada para adaptarse a su horario abierto los siete das de la semana con horario extendido .

- Winners received prestigious award in recognition of their latest innovations in life sciences advancement

GILBERT, Ariz., March 21, 2025 /PRNewswire/ -- Getting quality medical care just got easier in Gilbert! MY DR NOW is opening a brand-new primary care clinic designed to fit into your schedule-open seven days a week with extended hours.